The efficacy of montelukast monotherapy in moderate persistent asthmatic children

Iranian Journal of Allergy, Asthma and Immunology

Volumn 8, Issue 3, 2009, Pages 169-170

  Igde, Mahir ^a   Anlar, Fehim Yasar ^b  

^a Division of Pediatric Allergy Samsun Gynecology   (Turkey)

^b BAYINDIR HOSPITAL   (Turkey)

Author keywords

Asthma; Efficacy; Leukotriene antagonists; Montelukast; Pediatrics

Indexed keywords

BUDESONIDE; MONTELUKAST;

ARTICLE; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG TOLERABILITY; HUMAN; MODERATE PERSISTENT ASTHMA; MONOTHERAPY; SPIROMETRY; VIRUS INFECTION;

ACETATES; ADOLESCENT; ASTHMA; BUDESONIDE; CHILD; DRUG THERAPY, COMBINATION; HUMANS; LEUKOTRIENE ANTAGONISTS; PROSPECTIVE STUDIES; QUINOLINES;

EID: 76749146881     PISSN: 17351502     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Johnston SL, Pattemore PK, Sanderson G, Smith S, Lampe F, Josephs L, et al. Community study of the role of viral infections in exacerbations of asthma in 9-11 year old children. BMJ 1995; 310(6989):1225-9.
2. Bisgaard H, Zielen S, Garcia-Garcia ML, Johnston SL, Gilles L, Menten J, et al. Montelukast reduces asthma exacerbations in 2-to 5-year-old children with intermittent asthma. Am J Respir Crit Care Med. 2005; 171(4):315-22.
3. Powell H, Gibson PG. Inhaled corticosteroid doses in asthma:an evidence-based approach. Med J Aust 2003; 178(5):223-5.
4. Szefler SJ, Martin RJ, King TS, Boushey HA, Cherniack RM, Chinchilli VM, et al.Significant variability in response to inhaled corticosteroids for persistent asthma. J Allergy Clin Immunol 2002; 109(3):410-8.
5. Loeb JS, Blower WC, Feldstein JF, Koch BA, Munlin AL, Hardie WD..Acceptability and Repeatability of Spirometry in Children Using Updated ATS/ERS Criteria. Pediatric Pulmonol 2008; 43(10):1020-4.
6. Koopmans JG, Lutter R, Jansen HM, Van der Zee JS. Clinically masked increases in bronchial inflammation in guideline-treated persistent asthma. Pulm Pharmacol Ther 2006; 19(6):397-403.